EZH2 and myelodysplastic syndrome: In MDS and T-ALL sequencing studies, EZH2 mutations appear to disrupt the catalytic SET domain resulting in the loss of function of the gene (Ernst et al., 2010; Nikoloski et al., 2010; Zhang et al., 2012).